Seq #,Peptide start,Peptide end,Peptide,IC50,Allele
1,92,100,DTAMYYCVR,5.84,HLA-A*68:01
1,59,67,TTYYADSVK,7.70,HLA-A*68:01
1,149,157,FPEPVTVTW,9.33,HLA-B*53:01
1,164,172,SGVHTFPAV,15.44,HLA-A*02:06
1,30,38,NIYAMNWVR,20.49,HLA-A*68:01
1,178,186,YTLSSSVTV,23.36,HLA-A*02:06
1,202,210,HPASATSVD,23.42,HLA-B*35:01
1,80,88,MLYLQMNNL,25.35,HLA-A*02:03
1,137,145,SMVTLGCLV,29.17,HLA-A*02:03
1,92,100,DTAMYYCVR,30.62,HLA-A*33:01
1,176,184,DLYTLSSSV,32.21,HLA-A*02:03
1,172,180,VLQSDLYTL,33.82,HLA-A*02:01
1,30,38,NIYAMNWVR,33.97,HLA-A*33:01
1,59,67,TTYYADSVK,36.67,HLA-A*11:01
1,58,66,YTTYYADSV,38.25,HLA-A*68:02
1,110,118,TTLTVSSAV,38.25,HLA-A*68:02
1,180,188,LSSSVTVPV,38.42,HLA-A*68:02
1,119,127,KTPPSVYPL,38.81,HLA-A*32:01
1,29,37,FNIYAMNWV,45.98,HLA-A*68:02
1,53,61,SQSNNYTTY,48.87,HLA-B*15:01
1,208,216,SVDKAISPV,51.59,HLA-A*02:06
1,58,66,YTTYYADSV,57.09,HLA-A*02:06
1,50,58,RIRSQSNNY,57.94,HLA-A*30:01
1,30,38,NIYAMNWVR,60.32,HLA-A*31:01
1,172,180,VLQSDLYTL,64.56,HLA-A*02:03
1,27,35,FTFNIYAMN,65.09,HLA-A*68:01
1,11,19,LVQPKGSLK,70.36,HLA-A*11:01
1,191,199,WPSEAVTCN,71.88,HLA-B*35:01
1,50,58,RIRSQSNNY,72.86,HLA-A*30:02
1,169,177,FPAVLQSDL,80.33,HLA-B*07:02
1,149,157,FPEPVTVTW,80.83,HLA-B*35:01
1,80,88,MLYLQMNNL,91.43,HLA-A*02:01
1,24,32,ASGFTFNIY,91.72,HLA-A*30:02
1,137,145,SMVTLGCLV,94.00,HLA-A*02:01
1,161,169,SLGSGVHTF,94.19,HLA-B*15:01
1,54,62,QSNNYTTYY,96.06,HLA-A*01:01
1,178,186,YTLSSSVTV,97.30,HLA-A*02:01
1,59,67,TTYYADSVK,102.05,HLA-A*03:01
1,89,97,KTEDTAMYY,105.09,HLA-A*01:01
1,169,177,FPAVLQSDL,107.05,HLA-B*35:01
1,183,191,SVTVPVSTW,107.72,HLA-B*58:01
1,94,102,AMYYCVRQM,111.94,HLA-B*15:01
1,28,36,TFNIYAMNW,123.11,HLA-B*58:01
1,50,58,RIRSQSNNY,125.60,HLA-B*15:01
1,62,70,YADSVKDRF,131.70,HLA-B*35:01
1,54,62,QSNNYTTYY,132.53,HLA-B*58:01
1,39,47,QAPGKGLEW,134.68,HLA-B*58:01
1,117,125,AVKTPPSVY,136.77,HLA-B*15:01
1,27,35,FTFNIYAMN,138.23,HLA-A*68:02
1,178,186,YTLSSSVTV,139.18,HLA-A*68:02
1,53,61,SQSNNYTTY,144.70,HLA-A*30:02
1,125,133,YPLAPGGGA,145.51,HLA-B*07:02
1,77,85,SQSMLYLQM,146.22,HLA-B*15:01
1,111,119,TLTVSSAVK,149.55,HLA-A*03:01
1,185,193,TVPVSTWPS,163.53,HLA-A*68:02
1,72,80,ISRDDSQSM,164.82,HLA-B*15:01
1,31,39,IYAMNWVRQ,165.44,HLA-A*24:02
1,208,216,SVDKAISPV,174.82,HLA-A*68:02
1,47,55,WVARIRSQS,180.96,HLA-A*68:02
1,54,62,QSNNYTTYY,182.16,HLA-A*30:02
1,117,125,AVKTPPSVY,186.41,HLA-A*30:02
1,151,159,EPVTVTWNA,191.69,HLA-A*68:02
1,92,100,DTAMYYCVR,192.07,HLA-A*31:01
1,111,119,TLTVSSAVK,193.86,HLA-A*68:01
1,21,29,SCAASGFTF,194.35,HLA-B*35:01
1,194,202,EAVTCNVAH,196.15,HLA-B*35:01
1,11,19,LVQPKGSLK,199.43,HLA-A*03:01
1,208,216,SVDKAISPV,212.87,HLA-A*02:01
1,89,97,KTEDTAMYY,215.01,HLA-A*30:02
1,91,99,EDTAMYYCV,226.25,HLA-A*68:02
1,199,207,NVAHPASAT,228.34,HLA-A*68:02
1,169,177,FPAVLQSDL,231.68,HLA-B*53:01
1,176,184,DLYTLSSSV,243.84,HLA-A*02:01
1,98,106,CVRQMGDYW,265.03,HLA-B*58:01
1,111,119,TLTVSSAVK,281.38,HLA-A*11:01
1,74,82,RDDSQSMLY,281.55,HLA-A*01:01
1,24,32,ASGFTFNIY,299.92,HLA-B*15:01
1,54,62,QSNNYTTYY,299.92,HLA-B*15:01
1,19,27,KISCAASGF,304.79,HLA-B*15:01
1,191,199,WPSEAVTCN,306.11,HLA-B*53:01
1,170,178,PAVLQSDLY,317.38,HLA-B*35:01
1,89,97,KTEDTAMYY,321.59,HLA-A*11:01
1,98,106,CVRQMGDYW,330.99,HLA-B*57:01
1,54,62,QSNNYTTYY,340.64,HLA-A*11:01
1,23,31,AASGFTFNI,340.64,HLA-B*58:01
1,90,98,TEDTAMYYC,353.92,HLA-B*40:01
1,62,70,YADSVKDRF,356.35,HLA-B*53:01
1,28,36,TFNIYAMNW,381.44,HLA-A*23:01
1,183,191,SVTVPVSTW,412.88,HLA-B*57:01
1,147,155,GYFPEPVTV,470.36,HLA-A*23:01
1,87,95,NLKTEDTAM,470.49,HLA-B*08:01
1,202,210,HPASATSVD,470.85,HLA-B*53:01
1,52,60,RSQSNNYTT,471.48,HLA-A*30:02
1,65,73,SVKDRFTIS,471.57,HLA-B*08:01
1,174,182,QSDLYTLSS,487.02,HLA-A*01:01
1,97,105,YCVRQMGDY,501.72,HLA-A*30:02
1,140,148,TLGCLVNGY,522.40,HLA-B*15:01
1,34,42,MNWVRQAPG,537.09,HLA-A*33:01
1,140,148,TLGCLVNGY,550.12,HLA-A*30:02
1,81,89,LYLQMNNLK,572.04,HLA-A*23:01
1,21,29,SCAASGFTF,591.06,HLA-A*24:02
1,39,47,QAPGKGLEW,600.92,HLA-B*57:01
1,149,157,FPEPVTVTW,615.02,HLA-B*07:02
1,28,36,TFNIYAMNW,684.86,HLA-B*44:02
1,24,32,ASGFTFNIY,715.40,HLA-A*01:01
1,60,68,TYYADSVKD,773.80,HLA-A*24:02